This document presents an overview of a group project on R&D in UK pharmaceutical companies. It outlines the presentation structure, which includes an overview, history of the UK pharma industry, problem definition, research methodology, challenges and solutions. It discusses how competition has increased the need for R&D and innovation. It examines the relationship between company size, R&D expenditures, staff size, and level of innovation. The problem definition looks at how the UK is falling behind competitors and potential solutions. The research methodology analyzes the hypothesis and indicators considered like patents, publications, drugs produced, R&D expenditures and staff size. It also discusses the data resources, classification, additional resources, challenges encountered and solutions.